Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
Tag: IP newsletter
Dodged bullet or missed opportunity with CHEO settlement?: Richard Owens for the MLI IP newsletter
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
Stop the TPP-IP media pile-on: Richard Owens for the MLI IP newsletter
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
-
Rushing to death in Canada’s MAiD regime: Ramona Coelho for Inside Policy
-
Why are Western Canadian oil prices so strong?: Rory Johnston for Inside Policy
-
Canada’s conservatives care about freedom—except in health care: Shawn Whatley in the Hub
-
How gender activists stole the media, distorted medicine, and hurt Canadian kids: Mia Hughes for Inside Policy
-
How Poilievre can improve healthcare in Canada: Shawn Whatley in Troy Media
